Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australian Male Contraceptive Draws Little Drug Maker Interest

This article was originally published in PharmAsia News

Executive Summary

Australian researchers say they have developed a male injectable contraceptive as effective as the pill has been for women. Trials show the testosterone-based drug that suppresses sperm output to be as much as 95 percent effective when taken four times a year. But a leading researcher said pharmaceutical companies that were involved in development have withdrawn from the project and others have shown little interest in it. The research also has drawn little interest and funding from the Australian government. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts